schliessen

Filtern

 

Bibliotheken

On the route to combined evidence from OC and HRT/ERT

The understanding of cardiovascular mechanisms and how they translate into clinical risk should go hand in hand with current epidemiological knowledge when guidelines for optimal prescription of hormonal treatment are prepared. The clinical benefits of both oral contraceptives and hormone replacemen... Full description

Journal Title: The European journal of contraception & reproductive health care 2002-12-01, Vol.7 (4), p.185-198
Main Author: Skouby, Sven O
Other Authors: Jespersen, Jørgen , Kluft, Cornelis , Lowe, Gordon D O , Norris, Lucy , Samsioe, Göran , Stevenson, John
Format: Electronic Article Electronic Article
Language: English
Subjects:
Quelle: Alma/SFX Local Collection
Publisher: England: Informa Healthcare
ID: ISSN: 1362-5187
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: cdi_ingenta_smallpubs_apl_ejc_2002_00000007_00000004_art00001
title: On the route to combined evidence from OC and HRT/ERT
format: Article
creator:
  • Skouby, Sven O
  • Jespersen, Jørgen
  • Kluft, Cornelis
  • Lowe, Gordon D O
  • Norris, Lucy
  • Samsioe, Göran
  • Stevenson, John
subjects:
  • ADIPOSITAS
  • Adult
  • Aged
  • ANIMAL MODEL
  • Animals
  • BIOMARKERS
  • Birth control
  • BLOOD PRESSURE
  • Cardiovascular disease
  • CARDIOVASCULAR DISEASES
  • Cardiovascular Diseases - prevention & control
  • Clinical Medicine
  • CONSENSUS DEVELOPMENT
  • Contraceptives, Oral - administration & dosage
  • Contraceptives, Oral - adverse effects
  • Disease Models, Animal
  • EPIDEMIOLOGY
  • ESBJERG CONFERENCE
  • ESTROGEN
  • Estrogen Replacement Therapy - adverse effects
  • Estrogen Replacement Therapy - standards
  • Estrogen Replacement Therapy - trends
  • Europe
  • Female
  • Forecasting
  • GLUCOSE
  • Health risk assessment
  • HEMOSTASIS
  • HORMONE REPLACEMENT THERAPY
  • Hormone Replacement Therapy - adverse effects
  • Hormone Replacement Therapy - standards
  • Hormone Replacement Therapy - trends
  • Humans
  • INFLAMMATION
  • Klinisk medicin
  • LIPID
  • Medical and Health Sciences
  • Medicin och hälsovetenskap
  • Middle Aged
  • Obstetrics, Gynecology and Reproductive Medicine
  • ORAL CONTRACEPTIVES
  • Osteoporosis, Postmenopausal - prevention & control
  • PROGESTIN
  • Randomized Controlled Trials as Topic
  • Reproduktionsmedicin och gynekologi
  • Risk Assessment
  • RISK FACTORS
  • THROMBOSIS
  • Treatment Outcome
  • VESSEL WALL
ispartof: The European journal of contraception & reproductive health care, 2002-12-01, Vol.7 (4), p.185-198
description: The understanding of cardiovascular mechanisms and how they translate into clinical risk should go hand in hand with current epidemiological knowledge when guidelines for optimal prescription of hormonal treatment are prepared. The clinical benefits of both oral contraceptives and hormone replacement therapy are clear. Further improvement in relation to cardiovascular disease risk is mainly to be sought through endeavors with new preparations and improved use of existing preparations during recognition of susceptible individuals. Both routes of development should be undertaken and may mutually enhance safe and efficient use and, thus, support the effort of improving reproductive health in women from puberty through to the menopausal period.
language: eng
source: Alma/SFX Local Collection
identifier: ISSN: 1362-5187
fulltext: fulltext
issn:
  • 1362-5187
  • 1473-0782
url: Link


@attributes
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
RANK1.7730814
LOCALfalse
PrimoNMBib
record
control
sourceidpubtec_pubme
recordidTN_cdi_ingenta_smallpubs_apl_ejc_2002_00000007_00000004_art00001
sourceformatXML
sourcesystemPC
ingidapl/ejc/2002/00000007/00000004/art00001
sourcerecordidapl/ejc/2002/00000007/00000004/art00001
originalsourceidFETCH-LOGICAL-c2662-44c72226e16bf1f64c6d42e794a69ee2c584af8f72cb8eab161e36a3df27dd763
addsrcrecordideNpFkEuLVDEQhYMozji68A9IcOeinbxuJb1TmtERGhqGdh3yqOht7svkXgf_vWluOxYUdRYf51CHkLecfeTMsFvNJTAlwTwj11xpuWHaiOdVSxCbhht9RV6VcmKMy0q9JFdcQAOSiWvSHAY6_0Sax2VGOo80jL1vB4wUf7cRh4A05bGnhx11Q6T3D8fbu4fja_Iiua7gm8u9Id-_3B1395v94eu33ef9Jgio0UoFLYQA5OATT6ACRCVQb5WDLaIIjVEumaRF8Aad58BRgpMxCR2jBnlD9qtvecRp8XbKbe_yHzu61nbLVNfXtQVtg8EH5aXdCp2sYsCtZ5pb4yBF0CpKI6rd-9VuyuOvBctsT-OSh_qBFYxB03B1hj6sUMhjKRnTUypn9ly3faq7su8uhovvMf4nL_1W4NMKtMMPHGZnS--6rtLFuqmzeArnZGHZOvqfUNbl-Sy4_AuoEInE
sourcetypeOpen Access Repository
isCDItrue
recordtypearticle
pqid200655142
display
typearticle
titleOn the route to combined evidence from OC and HRT/ERT
sourceAlma/SFX Local Collection
creatorSkouby, Sven O ; Jespersen, Jørgen ; Kluft, Cornelis ; Lowe, Gordon D O ; Norris, Lucy ; Samsioe, Göran ; Stevenson, John
creatorcontribSkouby, Sven O ; Jespersen, Jørgen ; Kluft, Cornelis ; Lowe, Gordon D O ; Norris, Lucy ; Samsioe, Göran ; Stevenson, John ; Writing Group for the 3rd European Conference on Sex Steroids and Cardiovascular Diseases
descriptionThe understanding of cardiovascular mechanisms and how they translate into clinical risk should go hand in hand with current epidemiological knowledge when guidelines for optimal prescription of hormonal treatment are prepared. The clinical benefits of both oral contraceptives and hormone replacement therapy are clear. Further improvement in relation to cardiovascular disease risk is mainly to be sought through endeavors with new preparations and improved use of existing preparations during recognition of susceptible individuals. Both routes of development should be undertaken and may mutually enhance safe and efficient use and, thus, support the effort of improving reproductive health in women from puberty through to the menopausal period.
identifier
0ISSN: 1362-5187
1EISSN: 1473-0782
2DOI: 10.1080/713604368
3PMID: 12656302
4CODEN: ECRCFK
languageeng
publisherEngland: Informa Healthcare
subjectADIPOSITAS ; Adult ; Aged ; ANIMAL MODEL ; Animals ; BIOMARKERS ; Birth control ; BLOOD PRESSURE ; Cardiovascular disease ; CARDIOVASCULAR DISEASES ; Cardiovascular Diseases - prevention & control ; Clinical Medicine ; CONSENSUS DEVELOPMENT ; Contraceptives, Oral - administration & dosage ; Contraceptives, Oral - adverse effects ; Disease Models, Animal ; EPIDEMIOLOGY ; ESBJERG CONFERENCE ; ESTROGEN ; Estrogen Replacement Therapy - adverse effects ; Estrogen Replacement Therapy - standards ; Estrogen Replacement Therapy - trends ; Europe ; Female ; Forecasting ; GLUCOSE ; Health risk assessment ; HEMOSTASIS ; HORMONE REPLACEMENT THERAPY ; Hormone Replacement Therapy - adverse effects ; Hormone Replacement Therapy - standards ; Hormone Replacement Therapy - trends ; Humans ; INFLAMMATION ; Klinisk medicin ; LIPID ; Medical and Health Sciences ; Medicin och hälsovetenskap ; Middle Aged ; Obstetrics, Gynecology and Reproductive Medicine ; ORAL CONTRACEPTIVES ; Osteoporosis, Postmenopausal - prevention & control ; PROGESTIN ; Randomized Controlled Trials as Topic ; Reproduktionsmedicin och gynekologi ; Risk Assessment ; RISK FACTORS ; THROMBOSIS ; Treatment Outcome ; VESSEL WALL
ispartofThe European journal of contraception & reproductive health care, 2002-12-01, Vol.7 (4), p.185-198
rightsCopyright CRC Press Dec 2002
lds50peer_reviewed
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
thumbnail$$Usyndetics_thumb_exl
backlink
0$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12656302$$D View this record in MEDLINE/PubMed
1$$Uhttps://lup.lub.lu.se/record/1125317$$DView record from Swedish Publication Index
search
creatorcontrib
0Skouby, Sven O
1Jespersen, Jørgen
2Kluft, Cornelis
3Lowe, Gordon D O
4Norris, Lucy
5Samsioe, Göran
6Stevenson, John
7Writing Group for the 3rd European Conference on Sex Steroids and Cardiovascular Diseases
title
0On the route to combined evidence from OC and HRT/ERT
1The European journal of contraception & reproductive health care
addtitleEur J Contracept Reprod Health Care
descriptionThe understanding of cardiovascular mechanisms and how they translate into clinical risk should go hand in hand with current epidemiological knowledge when guidelines for optimal prescription of hormonal treatment are prepared. The clinical benefits of both oral contraceptives and hormone replacement therapy are clear. Further improvement in relation to cardiovascular disease risk is mainly to be sought through endeavors with new preparations and improved use of existing preparations during recognition of susceptible individuals. Both routes of development should be undertaken and may mutually enhance safe and efficient use and, thus, support the effort of improving reproductive health in women from puberty through to the menopausal period.
subject
0ADIPOSITAS
1Adult
2Aged
3ANIMAL MODEL
4Animals
5BIOMARKERS
6Birth control
7BLOOD PRESSURE
8Cardiovascular disease
9CARDIOVASCULAR DISEASES
10Cardiovascular Diseases - prevention & control
11Clinical Medicine
12CONSENSUS DEVELOPMENT
13Contraceptives, Oral - administration & dosage
14Contraceptives, Oral - adverse effects
15Disease Models, Animal
16EPIDEMIOLOGY
17ESBJERG CONFERENCE
18ESTROGEN
19Estrogen Replacement Therapy - adverse effects
20Estrogen Replacement Therapy - standards
21Estrogen Replacement Therapy - trends
22Europe
23Female
24Forecasting
25GLUCOSE
26Health risk assessment
27HEMOSTASIS
28HORMONE REPLACEMENT THERAPY
29Hormone Replacement Therapy - adverse effects
30Hormone Replacement Therapy - standards
31Hormone Replacement Therapy - trends
32Humans
33INFLAMMATION
34Klinisk medicin
35LIPID
36Medical and Health Sciences
37Medicin och hälsovetenskap
38Middle Aged
39Obstetrics, Gynecology and Reproductive Medicine
40ORAL CONTRACEPTIVES
41Osteoporosis, Postmenopausal - prevention & control
42PROGESTIN
43Randomized Controlled Trials as Topic
44Reproduktionsmedicin och gynekologi
45Risk Assessment
46RISK FACTORS
47THROMBOSIS
48Treatment Outcome
49VESSEL WALL
issn
01362-5187
11473-0782
fulltexttrue
rsrctypearticle
creationdate2002
recordtypearticle
recordideNpFkEuLVDEQhYMozji68A9IcOeinbxuJb1TmtERGhqGdh3yqOht7svkXgf_vWluOxYUdRYf51CHkLecfeTMsFvNJTAlwTwj11xpuWHaiOdVSxCbhht9RV6VcmKMy0q9JFdcQAOSiWvSHAY6_0Sax2VGOo80jL1vB4wUf7cRh4A05bGnhx11Q6T3D8fbu4fja_Iiua7gm8u9Id-_3B1395v94eu33ef9Jgio0UoFLYQA5OATT6ACRCVQb5WDLaIIjVEumaRF8Aad58BRgpMxCR2jBnlD9qtvecRp8XbKbe_yHzu61nbLVNfXtQVtg8EH5aXdCp2sYsCtZ5pb4yBF0CpKI6rd-9VuyuOvBctsT-OSh_qBFYxB03B1hj6sUMhjKRnTUypn9ly3faq7su8uhovvMf4nL_1W4NMKtMMPHGZnS--6rtLFuqmzeArnZGHZOvqfUNbl-Sy4_AuoEInE
startdate20021201
enddate20021201
creator
0Skouby, Sven O
1Jespersen, Jørgen
2Kluft, Cornelis
3Lowe, Gordon D O
4Norris, Lucy
5Samsioe, Göran
6Stevenson, John
general
0Informa Healthcare
1Taylor & Francis Ltd
scope
0CGR
1CUY
2CVF
3ECM
4EIF
5NPM
6AAYXX
7CITATION
83V.
97X7
107XB
1188E
128AO
138FI
148FJ
158FK
168G5
17ABUWG
18AZQEC
19BENPR
20DWQXO
21FYUFA
22GHDGH
23GNUQQ
24GUQSH
25K9.
26M0S
27M1P
28M2O
29MBDVC
30PADUT
31PQEST
32PQQKQ
33PQUKI
34PRINS
35Q9U
36S0X
37ADTPV
38AOWAS
39D95
sort
creationdate20021201
titleOn the route to combined evidence from OC and HRT/ERT
authorSkouby, Sven O ; Jespersen, Jørgen ; Kluft, Cornelis ; Lowe, Gordon D O ; Norris, Lucy ; Samsioe, Göran ; Stevenson, John
facets
frbrtype5
frbrgroupidcdi_FETCH-LOGICAL-c2662-44c72226e16bf1f64c6d42e794a69ee2c584af8f72cb8eab161e36a3df27dd763
rsrctypearticles
prefilterarticles
languageeng
creationdate2002
topic
0ADIPOSITAS
1Adult
2Aged
3ANIMAL MODEL
4Animals
5BIOMARKERS
6Birth control
7BLOOD PRESSURE
8Cardiovascular disease
9CARDIOVASCULAR DISEASES
10Cardiovascular Diseases - prevention & control
11Clinical Medicine
12CONSENSUS DEVELOPMENT
13Contraceptives, Oral - administration & dosage
14Contraceptives, Oral - adverse effects
15Disease Models, Animal
16EPIDEMIOLOGY
17ESBJERG CONFERENCE
18ESTROGEN
19Estrogen Replacement Therapy - adverse effects
20Estrogen Replacement Therapy - standards
21Estrogen Replacement Therapy - trends
22Europe
23Female
24Forecasting
25GLUCOSE
26Health risk assessment
27HEMOSTASIS
28HORMONE REPLACEMENT THERAPY
29Hormone Replacement Therapy - adverse effects
30Hormone Replacement Therapy - standards
31Hormone Replacement Therapy - trends
32Humans
33INFLAMMATION
34Klinisk medicin
35LIPID
36Medical and Health Sciences
37Medicin och hälsovetenskap
38Middle Aged
39Obstetrics, Gynecology and Reproductive Medicine
40ORAL CONTRACEPTIVES
41Osteoporosis, Postmenopausal - prevention & control
42PROGESTIN
43Randomized Controlled Trials as Topic
44Reproduktionsmedicin och gynekologi
45Risk Assessment
46RISK FACTORS
47THROMBOSIS
48Treatment Outcome
49VESSEL WALL
toplevel
0peer_reviewed
1online_resources
creatorcontrib
0Skouby, Sven O
1Jespersen, Jørgen
2Kluft, Cornelis
3Lowe, Gordon D O
4Norris, Lucy
5Samsioe, Göran
6Stevenson, John
7Writing Group for the 3rd European Conference on Sex Steroids and Cardiovascular Diseases
collection
0Medline
1MEDLINE
2MEDLINE (Ovid)
3MEDLINE
4MEDLINE
5PubMed
6CrossRef
7ProQuest Central (Corporate)
8Health & Medical Collection
9ProQuest Central (purchase pre-March 2016)
10Medical Database (Alumni Edition)
11ProQuest Pharma Collection
12Hospital Premium Collection
13Hospital Premium Collection (Alumni Edition)
14ProQuest Central (Alumni) (purchase pre-March 2016)
15Research Library (Alumni Edition)
16ProQuest Central (Alumni Edition)
17ProQuest Central Essentials
18ProQuest Central
19ProQuest Central Korea
20Health Research Premium Collection
21Health Research Premium Collection (Alumni)
22ProQuest Central Student
23Research Library Prep
24ProQuest Health & Medical Complete (Alumni)
25Health & Medical Collection (Alumni Edition)
26Medical Database
27Research Library
28Research Library (Corporate)
29Research Library China
30ProQuest One Academic Eastern Edition
31ProQuest One Academic
32ProQuest One Academic UKI Edition
33ProQuest Central China
34ProQuest Central Basic
35SIRS Editorial
36SwePub
37SwePub Articles
38SWEPUB Lunds universitet
jtitleThe European journal of contraception & reproductive health care
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
au
0Skouby, Sven O
1Jespersen, Jørgen
2Kluft, Cornelis
3Lowe, Gordon D O
4Norris, Lucy
5Samsioe, Göran
6Stevenson, John
aucorpWriting Group for the 3rd European Conference on Sex Steroids and Cardiovascular Diseases
formatjournal
genrearticle
ristypeJOUR
atitleOn the route to combined evidence from OC and HRT/ERT
jtitleThe European journal of contraception & reproductive health care
addtitleEur J Contracept Reprod Health Care
date2002-12-01
risdate2002
volume7
issue4
spage185
epage198
pages185-198
issn1362-5187
eissn1473-0782
codenECRCFK
abstractThe understanding of cardiovascular mechanisms and how they translate into clinical risk should go hand in hand with current epidemiological knowledge when guidelines for optimal prescription of hormonal treatment are prepared. The clinical benefits of both oral contraceptives and hormone replacement therapy are clear. Further improvement in relation to cardiovascular disease risk is mainly to be sought through endeavors with new preparations and improved use of existing preparations during recognition of susceptible individuals. Both routes of development should be undertaken and may mutually enhance safe and efficient use and, thus, support the effort of improving reproductive health in women from puberty through to the menopausal period.
copEngland
pubInforma Healthcare
pmid12656302
doi10.1080/713604368